Compounds binding to p-selectin
AssigneeYamanouchi Europe B.V.
InventorsChantal Appeldoorn, Erik Anna Biessen, Thomas Molenaar, Johan Kuiper, Theodorus Van Berkel
Life of this patent
Estimating the term…
Abstract
The present invention relates to derivatives of compounds which bind selectively to the adhesion molecule human P-selectin, and particularly to such derivatives which comprise a peptide moiety or a functional equivalent of said peptide moiety and are represented by X(Ax)mA3A1A2A1Y. In addition, the invention relates to methods for preparing such compounds, to the use of such compounds in therapeutic or diagnostic methods and in pharmaceutical compositions, to binding molecules binding to said compounds and to a method for determining whether a compound is capable of binding to P-selectin.
Claims25
A compound with affinity to human P-selectin, which is a derivative of a peptide or a functional equivalent of said peptide represented by X(Ax)mA3A1A2A1Y, wherein:
- A1 is a D- or L-cysteine (C), or a D- or L-valine (V), or an analogue thereof;
- A2 is D- or L-aspartic acid (D) or an analogue thereof;
- A3 is D- or L-phenylalanine (F), or a D- or L-tryptophan (W), or an analogue thereof;
- Ax is D- or L-amino acid, selected from the group consisting of glutamic acid (E), aspartic acid (D), glycine (G) and cysteine (C);
- X marks the N-terminal side of said sequence and is hydrogen or a residue comprising 1 to 6 D- or L-amino acids or analogues thereof;
- Y marks the C-terminal side of said sequence and is —OH or a residue comprising 1 to 11 D- or L-amino acids or analogues thereof;
- wherein X and Y together may form a cyclic system;
- characterized in that at least one of X and Y or X+Y is substituted with the group R1-(Z)n-, wherein:
- -Z is selected from —CO—, —O—, —NR2—, and —CO—NR2— and wherein R1 and R2 are independently selected from:
- a) H;
- b) a (C1-C8)alkyl group;
- c) a (C2-C8)alkyl group, wherein at least one C-atom is replaced with a nitrogen, oxygen or sulphur atom;
- d) a (C6-C14)aryl group, which may be substituted with at least one group selected from a halogen, (C1-C6)alkyl, —CF3, —OH, —O—(C1-C6)alkyl, —COOH, —COO—(C1-C6-alkyl), —NO2, —NH2—, —NH—(C1-C6)alkyl, —N—((C1-C6)alkyl)2 and —SO3H;
- e) a heteroroaryl group which is selected from 5- or 6-membered ring systems and benzo-condensed ring systems, and has at least one heteroatom selected from the group consisting of nitrogen, oxygen and sulphur, wherein said heteroaryl group may be substituted with at least one group selected from the group consisting of a halogen, —(C1-C6)alkyl, —CF3, —OH, —O—(C1-C6)alkyl, —COOH, —COO—(C1-C6)alkyl, —NO2, —NH2, —NH—(C1-C6)alkyl, —N—((C1-C6)alkyl)2 and —SO3H;
- f) an aralkyl group comprising an alkyl group as defined in b) or c) and an aryl group or heteroaryl group as defined in d) or e);
- and wherein m and n are integers independently selected from 0 and 1, with the proviso that n is not 0 when R1 is H.
15-17. (canceled)
25-27. (canceled)
Dependencies are inferred from the claim text.